Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

- PMLiVE

Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects

EAGLES trial of 8,000 patients backs the smoking cessation drugs' safety

- PMLiVE

Gilead bags EU approval for next-generation HIV drug

Descovy expected to replace Truvada as the firm’s lead antiviral blockbuster

Matthew Simas joins Truveris board of directors

He brings experience from Alliance Health and IMS Health

- PMLiVE

Does safety sell medicines?

Is pharmacovigilance unnecessary policing or a strategic asset for pharma companies?

National Institute for Health and Care Excellence NICE logo

NICE changes tack on Sanofi’s prostate cancer drug Jevtana

Approves the therapy for NHS use after accepting undisclosed additional discount 

german flag

Germany planning to table pricing reforms ‘by the summer’

Proposed changes include replacing 12-month full price policy with €250m threshold

- PMLiVE

First online ADHD treatment test launched in the US

Qbtech brings its QbCheck assessment to market after winning FDA approval

- PMLiVE

Science doesn’t sell

Healthcare communications aren’t lacking in clinical data - what they need is a dose of advertising ideals

Syneos Health®

- PMLiVE

Dicerna appoints chief financial officer

Jack Green to take on the role on a permanent basis

- PMLiVE

Science doesn’t sell

Healthcare communications aren’t lacking in clinical data - what they need is a dose of advertising ideals

- PMLiVE

Perrigo promotes Neil Lister to UK leadership role

He will head up the firm's UK and Ireland business

Celgene building

Celgene: Patient voice often underrepresented in pricing debates

Dr Jackie Fouse says in the interests of transparency patients should be more involved

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links